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Abstract: The microenvironment of the central nervous system is important for neuronal function and development. Dur-
ing the early stages of embryo development the cephalic vesicles are filled by embryonic cerebrospinal fluid, a complex 
fluid containing different protein fractions, which contributes to the regulation of the survival, proliferation and neuro-
genesis of neuroectodermal stem cells. The protein content of embryonic cerebrospinal fluid from chick and rat embryos 
at the start of neurogenesis has already been determined. Most of the identified gene products are thought to be involved 
in the regulation of developmental processes during embryogenesis. However, due to the crucial roles played by embry-
onic cerebrospinal fluid during brain development, the embryological origin of the gene products it contains remains an 
intriguing question. According to the literature most of these products are synthesised in embryonic tissues other than the 
neuroepithelium. In this study we examined the embryological origin of the most abundant embryonic cerebrospinal fluid 
protein fractions by means of slot-blot analysis and by using several different embryonic and extraembryonic protein ex-
tracts, immunodetected with polyclonal antibodies. This first attempt to elucidate their origin is not based on the proteins 
identified by proteomic methods, but rather on crude protein fractions detected by SDS-PAGE analysis and to which 
polyclonal antibodies were specifically generated. Despite some of the limitations of this study, i.e. that one protein frac-
tion may contain more than one gene product, and that a specific gene product may be contained in different protein frac-
tions depending on post-translational modifications, our results show that most of the analysed protein fractions are not 
produced by the cephalic neuroectoderm but are rather stored in the egg reservoir; furthermore, few are produced by em-
bryo tissues, thus indicating that they must be transported from their production or storage sites to the cephalic cavities, 
most probably via embryonic serum. These results raise the question as to whether the transfer of proteins from these two 
embryo compartments is regulated at this early developmental stage. 
MAIN TEXT 
 The development of the CNS from relatively simple an-
lagen involves the simultaneous and interdependent action of 
various developmental mechanisms, including the establish-
ment of positional identities, morphogenesis and histogene-
sis. It has been demonstrated that diffusible molecules, such 
as growth factors and morphogens secreted locally by organ-
ising centres, regulate these processes by controlling neigh-
bouring cells in an autocrine/paracrine manner [1], and that 
they regulate the expression of a number of transcription 
factors through which complex molecular and genetic net-
works are established. 
 The architecture of the brain primordium reveals the ex-
istence of an internal cavity, the brain cavities, which in foe-
tuses and adults become the ventricular system of the brain, 
containing cerebrospinal fluid (CSF). It has been reported 
that embryonic cerebrospinal fluid (E-CSF), which contacts 
the apical surface of all the neuroepithelial cells of the ce-
phalic vesicles, with which it establishes a physiologically 
sealed system, plays important roles in brain development: 
(1) it exerts positive pressure against the neuroepithelial 
walls to generate expansive force [2-5]; (2) it contributes to 
the regulation of the survival, proliferation and neural differ-
entiation of neuroepithelial progenitor cells [4,6,7]; (3) it 
 
*Address correspondence to this author at the Departament de Genètica, 
Facultat de Biologia, Universitat de Barcelona, Av. Diagonal 645, 08028 
Barcelona, Catalonia, Spain; E-mal: dbueno@ub.edu 
collaborates with the isthmic organiser in regulating mesen-
cephalic gene expression during the establishment of the 
anterior CNS pattern [8]; and (4) it controls the formation of 
layers of neurones in the cerebral cortex, as well as neuronal 
proliferation at foetal stages [5,7,9]. 
 It has recently been shown that at the moment of maxi-
mum proliferation and differentiation of neuroepithelial pro-
genitor cells, the E-CSF proteomes of both avians (chick, at 
developmental stage HH24 according to Hamburger and 
Hamilton [10], as depicted in Bellairs and Osmond [11] and 
mammals (rodents, at 12.5-12.7 days post coitum; and hu-
mans, at CS 19-20) include molecules whose roles during 
development in systems other than E-CSF are related to the 
functions reported for this fluid [12-14]. In chick embryos 
[13], these molecules include gene products related to the 
extra-cellular matrix and the regulation of osmotic pressure, 
regulators of lipid metabolism, i.e. apolipoprotein AI and 
AIV, molecules involved in vitamin transport (e.g. retinol-
binding protein and transthyretin), and proteins related to 
cell quiescence and death, among others. Moreover, we have 
also recently reported the presence of FGF2 within the E-
CSF and its role in neural differentiation [15].
 
 Due to the crucial roles played by E-CSF during brain 
development, one intriguing question is the embryological 
origin of the gene products it contains. According to the lit-
erature, most of the molecules identified in chick E-CSF are 
not produced by the neuroectoderm itself but rather by other 
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embryonic structures; alternatively, they are stored in the 
yolk or white of the egg and are consequently uptaken by the 
chorioallantois membrane [13]. Interestingly, a significant 
number of proteins identified within E-CSF are also present 
in blood plasma, although there are important quantitative 
and qualitative differences between these two fluids [16]. In 
this study, we examined the embryological origin of the most 
abundant E-CSF protein fractions at HH24 by means of slot-
blot analysis and by using several different embryonic and 
extraembryonic protein extracts, this being achieved through 
the generation of polyclonal antibodies to the most abundant 
protein fractions. This study is not based on the proteins 
identified by proteomic methods but rather on crude protein 
fractions as detected by SDS-PAGE analysis [16]. 
 The developmental stage from which we obtained E-CSF 
was chosen for two main reasons. First and most important, 
this stage falls within the period at which the embryos show 
the highest rate of neural stem cell proliferation, and at 
which the process of neurogenesis starts. This is also the 
reason by which all currently available data on the role of 
chick E-CSF on early CNS formation have been focused at 
HH24 (E4). Second, at stages earlier than HH23 the cephalic 
cavities are too small to obtain enough E-CSF to perform the 
analysis. In this way, this work contributes some new data on 
the origin of the E-CSF protein content at the developmental 
stage showing the highest rate of neural stem cell prolifera-
tion and the starting of neurogenesis. 
 Fertile chicken eggs were incubated at 38°C in a humidi-
fied atmosphere to obtain chick embryos at the desired de-
velopmental stage, i.e. at E4 (HH24) (E is for embryonic day 
according to the beginning of incubation). To generate poly-
clonal antibodies, 1 ml of E-CSF obtained from 200 embryos 
at HH24 was in SDS-polyacrylamide gel electrophoreses 
(three gels at 7.5% and three gels at 12%) and subsequently 
stained with Silver Stain Kit (Bio-Rad). After identifying the 
21 most abundant E-CSF protein fractions previously de-
scribed [16], they were cut with a scalpel and homogenised 
in PBS by sonication. For mice immunisation, the protocol 
described by Harlow and Lane [17] was followed. Briefly, 
300 μl of each preparation was injected intraperitoneally into 
eight-week old BALB/C female mice (two mice for each 
protein fraction). The injection was repeated twice, at a two-
week interval. Finally, mice were injected daily for three 
days, blood was removed by post-mortem intracardiac injec-
tion, and serum recovered after centrifugation. Polyclonal 
antibodies were purified by protein-A columns (Sigma, 
82487). All animal experimentation was performed accord-
ing to local animal welfare regulations. The specificity of the 
obtained antibodies was checked by western-blot analysis to 
the protein fractions used to generate them using standard 
protocols (not shown). 
 For slot-blot analysis, embryonic samples were applied to 
nitrocellulose membrane (Hybond-N) using a Micro-sample 
Filtration Manifold (Schleicher & Schuell, SRC 072/0) con-
nected to a vacuum pump. Samples were as follows: E-CSF, 
embryonic serum, and protein extracts from chorioallantois 
membrane, total embryo, dorsal cephalic neuroectoderm 
from which most of the subjacent mesenchyma had been 
dissected off, yolk and white of the egg. All samples were 
taken from fertile eggs after four days of incubation. After 
extensive washes in PBS, tissue samples were homogenised 
in PBS. Yolk and white of the egg were diluted 1/10 in PBS. 
After sample application, membranes were dried to fix the 
proteins and the presence of molecules was detected with the 
raised polyclonal antibodies diluted at 1/5,000 in PBS. As 
secondary antibody a goat anti-mouse conjugated to HRP (at 
1/2,000; Sigma, A0168) was used. 
 It is important to note that total embryonic tissues con-
tained some remaining E-CSF and embryonic serum within 
the neural tube and blood vessels, respectively, and that 
chorioallantois membrane also contained some remaining 
embryonic serum within the blood vessels. Ventral telen-
cephalic and mesencephalic tissues were not used due to the 
difficulty of dissecting them from other embryonic tissues, 
for example, from the underlying mesenchyma. 
 The logic behind this experiment is as follows: (1) pro-
tein fractions detected either in the yolk or white of the egg 
as well as in E-serum are most probably taken from the egg 
reservoir by the chorioallantois membrane and transported to 
the E-CSF by means of E-serum; (2) protein fractions de-
tected in the chorioallantois membrane and E-serum but in 
neither the yolk nor white of the egg are those eligible to be 
produced by the chorioallantois membrane and transported 
to the E-CSF by means of E-serum; (3) protein fractions de-
tected in the total embryo tissues but in neither the egg res-
ervoir nor the neuroectoderm are those eligible to be pro-
duced by embryonic tissues or organs other than the dorsal 
neuroectoderm; and (4) protein fractions detected mostly in 
the neuroectoderm are those eligible to be produced by this 
tissue. In all cases, proteins must be detected within the E-
CSF as this is the source of the antigens used for immunisa-
tion. It is important to note some of the limitations of this 
study, i.e. that one protein fraction may contain more than 
one gene product, and that a specific gene product may be 
contained in different protein fractions depending on post-
translational modifications. Similarly, a specific polyclonal 
antibody may recognise epitopes present in different gene 
products. 
 Protein fractions obtained by SDS-PAGE were named A 
to U according to Gato et al. [16] (Fig. 1A). The mass spec-
trometry analysis of these bands was not conclusive most 
probably due to the presence of some underrepresented gene 
products in the protein fractions, which yield some peptides 
that masked the identification of the tryptic digests. Chick E-
CSF proteins identified by mass spectrum analysis from a 2-
DE have been described in Parada et al. [13]. For the as-
signed nature of A to U protein fractions on the basis of their 
SDS-PAGE molecular mass, see Gato et al. [16]. 
 This experiment showed that most of the analysed pro-
tein fractions (76.19%) were present either in the yolk or 
white of the egg, and only 23.81% were restricted to embryo 
tissues (Fig. 1B). All protein fractions that were not present 
in either the yolk or white of the egg (i.e. fractions E, I, N, O 
and U) were also absent in chorioallantois extracts, further 
indicating that they were produced by embryo tissues. Simi-
larly, all protein fractions that were present in the yolk or 
white of the egg were also present in the chorioallantois ex-
tracts and in E-serum, suggesting that this is the route they 
follow to reach E-CSF. As expected, all protein fractions 
including those coming from the egg reservoir and those 
produced by the embryo tissues were detected in total em-
bryo protein extract. No proteins produced exclusively by 
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the chorioallantois membrane were detected, as the poly-
clonal antibodies which immunoreacted with chorioallantois 
membrane extract also immunoreacted with either the yolk 
or the white or the egg. With respect to proteins produced by 
embryo tissues, fractions I and O were detected in neuroec-
todermal extracts but fractions N and U were not, thus sug-
gesting that the former were produced by the neuroectoderm 
and the latter by other embryonic tissues, which could in-
clude ventral neuroectoderm as this was not included in the 
analysis. 
 Despite the abovementioned limitations of this study, 
which do not allow assigning the precise embryological ori-
gin to particular known proteins, the overall results indicate 
that most of the analysed protein fractions are not produced 
by the neuroectoderm, and thus they may be transported 
from their production or storage sites to the cephalic cavities, 
most probably via E-serum. The extraneural origin of most 
of these protein fractions, together with the crucial roles ex-
erted by the analysed gene products of this fluid and the dif-
ferences reported for E-CSF and embryonic serum composi-
tion [16, 18], raise the question as to whether the transfer of 
these proteins from these two embryo compartments is regu-
lated, thus suggesting the existence of some kind of blood-
CSF interface for protein transfer. In this regard, it is known 
that choroids plexuses, which fulfil this function in foetuses 
and adults, develop later in development, i.e. according to 
Bellairs and Osmond [11]
 
they are first detected at the mor-
phological level at E7
 
in chick embryos. The particular 
analysis of these issues merits further experimentation. 
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Fig. (1). Embryological origin of the most abundant E-CSF protein fractions at the beginning of primary neurogenesis. A) Silver staining of 
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considered as normalised background. Abbreviations: Emb, total embryo extract (which includes some remaining E-CSF from the neural 
tube and some remaining E-serum from the blood vessels); E-CSF, embryonic cerebrospinal fluid; E-serum, embryonic serum; Wh-egg, 
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